Viswanath Arutla

929 total citations
27 papers, 774 citations indexed

About

Viswanath Arutla is a scholar working on Organic Chemistry, Molecular Biology and Toxicology. According to data from OpenAlex, Viswanath Arutla has authored 27 papers receiving a total of 774 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Organic Chemistry, 12 papers in Molecular Biology and 5 papers in Toxicology. Recurrent topics in Viswanath Arutla's work include Synthesis and biological activity (10 papers), Synthesis and Biological Evaluation (6 papers) and Bioactive Compounds and Antitumor Agents (5 papers). Viswanath Arutla is often cited by papers focused on Synthesis and biological activity (10 papers), Synthesis and Biological Evaluation (6 papers) and Bioactive Compounds and Antitumor Agents (5 papers). Viswanath Arutla collaborates with scholars based in India, United States and Saudi Arabia. Viswanath Arutla's co-authors include Ähmed Kamal, M. Janaki Ramaiah, S.N.C.V.L. Pushpavalli, G. Ramakrishna, M. Kashi Reddy, P. V. K. Raju, Kalkunte S. Srivenugopal, Manika Pal‐Bhadra, Surendra R. Punganuru and E. Vijaya Bharathi and has published in prestigious journals such as Cancer Research, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Viswanath Arutla

27 papers receiving 764 citations

Peers

Viswanath Arutla

PHARM

TOXIC

ONCOL

Martyn Inman United Kingdom

C. V. Kavitha India

Sébastien Fortin Canada

Daqian Zhu China

Zhi‐Jie Ni United States

Andrew Madin United Kingdom

Keith C. Ellis United States

David C. Limburg United States

Zhao‐Kui Wan United States

Douglas G. Batt United States

Martyn Inman United Kingdom

Viswanath Arutla

792 ×1.4

233 ×0.9

31 ×0.5

PHARM

58 ×1.0

TOXIC

38 ×0.7

ONCOL

Citations per year, relative to Viswanath Arutla Viswanath Arutla (= 1×) peers Martyn Inman

Countries citing papers authored by Viswanath Arutla

Since Specialization

Citations

This map shows the geographic impact of Viswanath Arutla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viswanath Arutla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viswanath Arutla more than expected).

Fields of papers citing papers by Viswanath Arutla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viswanath Arutla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viswanath Arutla. The network helps show where Viswanath Arutla may publish in the future.

Co-authorship network of co-authors of Viswanath Arutla

This figure shows the co-authorship network connecting the top 25 collaborators of Viswanath Arutla. A scholar is included among the top collaborators of Viswanath Arutla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viswanath Arutla. Viswanath Arutla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Srivenugopal, Kalkunte S., Viswanath Arutla, Surendra R. Punganuru, & Amir Khan. (2024). Application of a Specific and Sensitive NQO1 Turn-On Near-Infrared Fluorescence Probe for Live Cancer Cell and Xenografted Tumor Imaging in Nude Mice. Methods in molecular biology. 2755. 63–74. 1 indexed citations

Al-Obaide, Mohammed A. I., Viswanath Arutla, Manny D. Bacolod, et al.. (2021). Genomic Space of MGMT in Human Glioma Revisited: Novel Motifs, Regulatory RNAs, NRF1, 2, and CTCF Involvement in Gene Expression. International Journal of Molecular Sciences. 22(5). 2492–2492. 6 indexed citations

Ji, Xun, et al.. (2020). Double-component diazeniumdiolate derivatives as anti-cancer agents. Bioorganic & Medicinal Chemistry. 28(8). 115405–115405. 4 indexed citations

Punganuru, Surendra R., Viswanath Arutla, Wei Zhao, et al.. (2020). Targeted Brain Tumor Therapy by Inhibiting the MDM2 Oncogene: In Vitro and In Vivo Antitumor Activity and Mechanism of Action. Cells. 9(7). 1592–1592. 15 indexed citations

Punganuru, Surendra R., Hanumantha Rao Madala, Viswanath Arutla, Ruiwen Zhang, & Kalkunte S. Srivenugopal. (2019). Characterization of a highly specific NQO1-activated near-infrared fluorescent probe and its application for in vivo tumor imaging. Scientific Reports. 9(1). 8577–8577. 34 indexed citations

Punganuru, Surendra R., Hanumantha Rao Madala, Viswanath Arutla, & Kalkunte S. Srivenugopal. (2018). Abstract 1952: Design and characterization of an NQO1-activated spiroisoindolinone derivative for glioma treatment. Cancer Research. 78(13_Supplement). 1952–1952. 1 indexed citations

Arutla, Viswanath, Joseph M. Leal, Xiaowei Liu, et al.. (2017). Prescreening of Nicotine Hapten Linkers in Vitro To Select Hapten-Conjugate Vaccine Candidates for Pharmacokinetic Evaluation in Vivo. ACS Combinatorial Science. 19(5). 286–298. 6 indexed citations

Kamal, Ähmed, Viswanath Arutla, M. Janaki Ramaiah, et al.. (2013). Synthesis and Biological Evaluation of Diaryl Ether Linked DC-81 Conjugates as Potential Antitumor Agents. Anti-Cancer Agents in Medicinal Chemistry. 13(10). 1590–1600. 4 indexed citations

Kamal, Ähmed, M. Kashi Reddy, & Viswanath Arutla. (2013). The design and development of imidazothiazole–chalcone derivatives as potential anticancer drugs. Expert Opinion on Drug Discovery. 8(3). 289–304. 41 indexed citations

10.

Kamal, Ähmed, M. Janaki Ramaiah, Y. V. V. Srikanth, et al.. (2013). 3-Diarylethyne quinazolinones: a new class of senescence inducers. MedChemComm. 4(3). 575–575. 8 indexed citations

11.

Kamal, Ähmed, Jaki R. Tamboli, M. Janaki Ramaiah, et al.. (2012). Anthranilamide–Pyrazolo[1,5‐a]pyrimidine Conjugates as p53 Activators in Cervical Cancer Cells. ChemMedChem. 7(8). 1453–1464. 12 indexed citations

12.

Kamal, Ähmed, M. Janaki Ramaiah, Y. V. V. Srikanth, et al.. (2012). 3‐Substituted 2‐Phenylimidazo[2,1‐b]benzothiazoles: Synthesis, Anticancer Activity, and Inhibition of Tubulin Polymerization. ChemMedChem. 7(2). 292–300. 43 indexed citations

13.

Kamal, Ähmed, et al.. (2012). Synthesis, biological evaluation of 5-carbomethoxymethyl-7-hydroxy-2-pentylchromone, 5-carboethoxymethyl-4′,7-dihydroxyflavone and their analogues. Bioorganic & Medicinal Chemistry Letters. 22(14). 4891–4895. 6 indexed citations

14.

Kamal, Ähmed, G. Ramakrishna, M. Janaki Ramaiah, et al.. (2012). Design, synthesis and biological evaluation of imidazo[1,5-a]pyridine–PBD conjugates as potential DNA-directed alkylating agents. MedChemComm. 4(4). 697–697. 32 indexed citations

15.

Kamal, Ähmed, G. Ramakrishna, P. V. K. Raju, et al.. (2011). Synthesis and anticancer activity of oxindole derived imidazo[1,5-a]pyrazines. European Journal of Medicinal Chemistry. 46(6). 2427–2435. 81 indexed citations

16.

Kamal, Ahmed, G. Ramakrishna, Veena Nayak, et al.. (2011). Design and synthesis of benzo[c,d]indolone-pyrrolobenzodiazepine conjugates as potential anticancer agents. Bioorganic & Medicinal Chemistry. 20(2). 789–800. 50 indexed citations

17.

Kamal, Ähmed, E. Vijaya Bharathi, M. Janaki Ramaiah, et al.. (2010). Synthesis, anticancer activity and apoptosis inducing ability of anthranilamide-PBD conjugates. Bioorganic & Medicinal Chemistry Letters. 20(11). 3310–3313. 13 indexed citations

18.

Kamal, Ähmed, E. Vijaya Bharathi, Jhansi Reddy, et al.. (2010). Synthesis and biological evaluation of 3,5-diaryl isoxazoline/isoxazole linked 2,3-dihydroquinazolinone hybrids as anticancer agents. European Journal of Medicinal Chemistry. 46(2). 691–703. 160 indexed citations

19.

Kamal, Ähmed, G. Ramakrishna, P. V. K. Raju, et al.. (2010). Synthesis and anti-cancer activity of chalcone linked imidazolones. Bioorganic & Medicinal Chemistry Letters. 20(16). 4865–4869. 67 indexed citations

20.

Kamal, Ähmed, E. Vijaya Bharathi, M. Janaki Ramaiah, et al.. (2009). Quinazolinone linked pyrrolo[2,1-c][1,4]benzodiazepine (PBD) conjugates: Design, synthesis and biological evaluation as potential anticancer agents. Bioorganic & Medicinal Chemistry. 18(2). 526–542. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact